分枝桿菌培養設備市場規模、佔有率和成長分析：按產品類型、測試類型、技術、最終用戶、應用和地區分類 - 產業預測，2026-2033年

2024 年全球分枝桿菌培養設備市場價值為 8.42 億美元，預計到 2025 年將成長至 9.0852 億美元，到 2033 年將成長至 16.6919 億美元，在預測期（2026-2033 年）內複合年成長率為 7.9%。

對抗生素抗藥性監測的日益重視正在推動分枝桿菌培養設備市場的成長。這是因為衛生部門正在尋求先進的平台來確認分枝桿菌分離株的表現型藥敏性。提供整合成像和人工智慧分析解決方案的公司正在透過最大限度地減少人工操作和加快報告速度來提高檢查室效率，最終改善患者預後並降低感染風險。例如，自動化MGIT系統與分析入口網站結合使用，已被證明能夠有效最佳化檢測結果的報告時間，創造資金籌措機會，並為製造商帶來盈利。這一趨勢正在為擴大服務合約鋪路，促進全球資源匱乏地區的業務成長，並推動與診斷測試開發公司的合作，從而全面提升分枝桿菌領域的診斷能力。

全球分枝桿菌培養設備市場促進因素

醫療專業人員對快速鑑定分枝桿菌感染疾病的需求日益成長，推動了檢查室對先進培養設備的需求。這些創新設備顯著縮短了培養時間，提高了檢測準確性，並簡化了工作流程，使臨床醫生能夠做出更明智的治療決策。因此，患者預後得到改善，疾病傳播風險降低。面對日益成長的高效培養技術需求，製造商正透過擴展產品線和加大研發投入來積極回應。這種診斷優勢日益被認可和廣泛應用的良性循環，正在推動全球分枝桿菌培養設備市場的整體成長。

全球分枝桿菌培養設備市場的限制因素

先進的分枝桿菌培養設備初期投資成本高昂，這對預算有限的小規模醫院和檢查室尤其構成重大挑戰。這些機構被迫將重點放在基本設備上，往往優先選擇價格較低的方案而非效率較低的方案，並經常推遲對高階培養技術的投資。因此，在價格敏感的市場領域，此類設備的普及速度正在放緩，阻礙了整體市場成長前景，直​​到出現更便利的資金籌措管道或設備成本降低為止。此外，冗長的法規核准流程也會延遲投資回報的實現，進一步阻礙了企業在該細分市場中拓展業務的努力。

分枝桿菌培養設備的全球市場趨勢

全球分枝桿菌培養系統市場正呈現即時檢測（PoC）培養系統快速普及的顯著趨勢。醫療專業人員日益需要分散式檢測解決方案，以便在患者所在位置或附近快速分析分枝桿菌感染疾病。這些創新設備體積小巧、介面友好，適用於門診、偏遠醫院和現場使用。透過最大限度地減少對中心檢查室的依賴，它們不僅縮短了檢體運輸時間，還加強了感染控制監測。製造商正優先考慮系統的穩健設計和電池續航力，力求將這些系統定位為提升全球醫療資源匱乏地區診斷能力的關鍵工具。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球分枝桿菌培養設備市場規模：依產品類型分類

• 自動化培養系統
• 手作文化體系
• 培養基
• 耗材和配件

全球分枝桿菌培養設備市場規模：依檢測類型分類

• 結核病（TB）
• 非結核分枝桿菌（NTM）

全球分枝桿菌培養設備市場規模：依技術分類

• 液體培養
• 固體的文化

全球分枝桿菌培養設備市場規模：依最終用戶分類

• 醫院
• 診斷檢查室
• 研究和學術機構
• 公共衛生研究所

全球分枝桿菌培養設備市場規模：依應用領域分類

• 臨床診斷
• 藥物敏感性試驗
• 調查

全球分枝桿菌培養設備市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• bioMerieux SA
• Becton, Dickinson and Company
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Merck KGaA
• Agilent Technologies, Inc.
• Hardy Diagnostics
• HiMedia Laboratories Pvt. Ltd.
• Titan Biotech Limited
• Liofilchem Srl
• Creative Diagnostics
• ZeptoMetrix LLC
• Microbiologics, Inc.
• COPAN Italia SpA
• Abbott Laboratories
• F. Hoffmann-La Roche Ltd.
• QIAGEN NV
• Revvity, Inc.
• Sysmex Corporation
• Nipro Corporation

結論與建議

Global Mycobacteria Culture Devices Market size was valued at USD 842.0 Million in 2024 and is poised to grow from USD 908.52 Million in 2025 to USD 1669.19 Million by 2033, growing at a CAGR of 7.9% during the forecast period (2026-2033).

The growing emphasis on monitoring antimicrobial resistance is propelling the market for mycobacteria culture devices, as health authorities seek advanced platforms to confirm the phenotypic susceptibility of mycobacterial isolates. Companies that offer solutions integrating imaging with AI-driven analytics are enhancing laboratory efficiency by minimizing manual processes and expediting reporting, ultimately improving patient outcomes and reducing transmission risks. For instance, an automated MGIT system, when coupled with an analytics portal, has proven effective in optimizing turnaround times, thus attracting funding opportunities and showcasing profitability for manufacturers. This trend paves the way for expanding service contracts, enabling geographic growth in resource-limited areas globally, and fostering collaborations with diagnostic test developers to enhance overall diagnostic capabilities in the mycobacterial segment.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Mycobacteria Culture Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Mycobacteria Culture Devices Market Segments Analysis

Global mycobacteria culture devices market is segmented by product type, test type, technology, end user, application and region. Based on product type, the market is segmented into Automated Culture Systems, Manual Culture Systems, Culture Media and Consumables & Accessories. Based on test type, the market is segmented into Tuberculosis (TB) and Non-Tuberculous Mycobacteria (NTM). Based on technology, the market is segmented into Liquid Culture and Solid Culture. Based on end user, the market is segmented into Hospitals, Diagnostic Laboratories, Research & Academic Institutes and Public Health Laboratories. Based on application, the market is segmented into Clinical Diagnostics, Drug Susceptibility Testing and Research. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Mycobacteria Culture Devices Market

The demand for faster identification of mycobacterial infections among healthcare providers is driving the need for advanced culture devices in laboratories. These innovative devices significantly reduce incubation times, enhance detection accuracy, and streamline workflow processes, thereby allowing clinicians to make better-informed therapeutic decisions. This, in turn, improves patient outcomes and reduces the risk of disease transmission. As the need for efficient culture technologies grows, manufacturers are responding by broadening their product offerings and investing in research and development. This cycle of increased adoption and awareness of diagnostic benefits is propelling the overall growth of the global mycobacteria culture devices market.

Restraints in the Global Mycobacteria Culture Devices Market

The high acquisition costs associated with advanced mycobacterial culture devices present a significant challenge, particularly for smaller hospitals and laboratories with constrained budgets. These institutions are compelled to focus on essential equipment, frequently postponing investment in higher-end culture technologies in favor of more affordable, albeit less efficient, options. As a result, price-sensitive segments of the market experience slower adoption rates, hindering overall growth prospects until there are more accessible financing options or reductions in device costs. Additionally, lengthy regulatory approval processes can delay the realization of return on investment, further complicating expansion efforts in this market segment.

Market Trends of the Global Mycobacteria Culture Devices Market

The Global Mycobacteria Culture Devices market is witnessing a significant trend toward the adoption of Point-of-Care culture systems. Healthcare providers are increasingly demanding decentralized testing solutions that facilitate the rapid analysis of mycobacterial infections directly at or near the patient's location. These innovative devices are designed with compact footprints and user-friendly interfaces, making them suitable for outpatient clinics, remote hospitals, and field settings. By minimizing reliance on centralized laboratories, they not only reduce sample transport delays but also enhance infection control monitoring. Manufacturers are prioritizing rugged designs and battery-operated functionalities, positioning these systems as vital tools for improving diagnostic capabilities in underserved areas globally.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Mycobacteria Culture Devices Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Automated Culture Systems
• Manual Culture Systems
• Culture Media
• Consumables & Accessories

Global Mycobacteria Culture Devices Market Size by Test Type & CAGR (2026-2033)

• Market Overview
• Tuberculosis (TB)
• Non-Tuberculous Mycobacteria (NTM)

Global Mycobacteria Culture Devices Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Liquid Culture
• Solid Culture

Global Mycobacteria Culture Devices Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Research & Academic Institutes
• Public Health Laboratories

Global Mycobacteria Culture Devices Market Size by Application & CAGR (2026-2033)

• Market Overview
• Clinical Diagnostics
• Drug Susceptibility Testing
• Research

Global Mycobacteria Culture Devices Market Size & CAGR (2026-2033)

• North America (Product Type, Test Type, Technology, End User, Application)
  • US
  • Canada
• Europe (Product Type, Test Type, Technology, End User, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Test Type, Technology, End User, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Test Type, Technology, End User, Application)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Test Type, Technology, End User, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• bioMerieux SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hardy Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HiMedia Laboratories Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Titan Biotech Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Liofilchem S.r.l.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZeptoMetrix LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microbiologics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• COPAN Italia S.p.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations